Press Releases

PARSIPPANY, N.J., Nov. 7, 2019 /PRNewswire/ -- Point of Care Network (POCN) is the largest network of nurse practitioners (NPs) and physician assistants (PAs) in America and started America's Top NP Program 3 years ago with the goal of recognizing and celebrating influential and impactful NPs practicing today. While physicians have been able to nominate their peer

VANCOUVER, British Columbia, Nov. 7, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc. (CSE: MYM) (CSE: MYM.CN)  (OTCBB: MYMMF) ("MYM" or the "Company") has signed a non-binding letter of intent with Crop Infrastructure Corp. ("Crop") to acquire all of the issued and outstanding shares in the capital of Crop, a company which owns cannabis and hemp assets

ATLANTA and TAMPA, Fla., Nov. 7, 2019 /PRNewswire/ -- More than 100,000 children in Geor

AUSTIN, Texas, Nov. 7, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE American:  VNRX) ("Volition") today announced it will host a conference call on Wednesday, November 13 at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter of 2019 in addition to providing a busine

DENVER, Nov. 7, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it will host a conference call to discuss operational and financial highlights from its third quarter 2019 on Monday, November 11, 2019 at 8:30 a.m. ET.

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- A leading global health and wellness agency, Evoke (www.evokegroup.com) announces the addition of Karsten Risch, MD, PhD,

SAN DIEGO, Nov. 7, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable inform

NASDAQ: CORV  TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) VANCOUVER, Nov. 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharm

DUBLIN, Nov. 7, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 15 abstracts sponsored by Jazz Pharmaceuticals, including one oral presentation, one abstract from a collaboration trial with MD Anderson Cancer Center (MD Anderson) and two abstracts from investigator-sponsored trials, will be presented at the 61st American

JERSEY CITY, N.J., Nov. 7, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive top-line results for its Phase 3 VANISH-303 study investigating the safety and efficacy of oral ibrexafungerp as a treatment for women with vulvov